Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line

References

• BELLOC, C., BAIRD, S., C „_,OSME, J., LECOEUR, S., GAUTIER, J.-C., CHALLINE, D., DE WAZIERS, I., FLINOES J.-P. and BEAUNE, P. H., 1996, Human cytochromes P450 expressed in Escherichiacoli: production of specific antibodies. Toxicology, 106, 207–219.
   Google Scholar
• BOLT, H. M., 1994, Interactions between clinically used drugs and oral contraceptives. Environmental Health Perspectives, 102 35–38.
   PubMedGoogle Scholar
• BOUCER, P. D. and HINES, R. N., 1995, In vitro binding and functional studies comparing the human CYP1A1 negative regulatory element with the orthologous sequences from rodent genes. CarcinogenesM 16, 383–392.
   PubMedGoogle Scholar
• CHASSEROT -GOLAZ, S. and BECK, G., 1992, How the potency of the steroid RU486 is related to P450 activities induced by dexamethasone and phenobarbital in rat hepatoma cells. Journal of Steroid Biochemistry and Molecular Biology, 41, 653–657.
   PubMedGoogle Scholar
• CHUNG, I. and BRFSNICK, E., 1994,3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma HepG2 cells as quantified by the reverse transcription-polymerase chain reaction. Archives of Biochemistry and Biophysics, 314, 75–81.
   PubMedGoogle Scholar
• CURI-PEDROSA, R., DAUJAT, M., PICARD, L., OURLIN, J. C., CLAIR, P., GERVOT, L., LESCA, P., DOMERGUE J., JOYEUX, H., FOURTANIER, G. and MAUREL, P., 1994, Omeprazole and lansoprazole are mixed inducers ofCYP1A and CYP3A in human hepatocytes in primary culture. Journal ofPharrnacology and Experimental Therapeutics, 269, 384–392.
   Google Scholar
• DAUJAT, M., PERYT, B., LESCA, P., FOURTANIER, G., DOMERGUE, J. and MAUREL, P., 1992, Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the AH receptor. Biochemical and Biophysical Research Communication. 188, 820–825.
   PubMed Web of Science ®Google Scholar
• DE MEY, C., MEINEKE, I., STEINITANS, V. W., HUBER, R., HARTMANN, M., BLIESATH, H. and WURST, W., 1994, Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction. International Journal of Clinical Pharmacology and Therapeutics, 32, 98–106.
   PubMedGoogle Scholar
• DIAZ, D., FABRE, L, DAUJAT, M., SAINT -ALBERT, B., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastro-enterology, 99, 737–747.
   Google Scholar
• DONATO, M. T., CASTELL, J. V. and GOMEZ-LECHO'N, M. J., 1994, Cytochrome P450 activities in pure and co-cultured rat hepatocytes. Effects of model inducers. In Vitro Cellular and Developmental Biology, 30A, 825–832.
   Google Scholar
• DONATO, M. T., HERRERO, E., GOMEZ-LECHO'N, M. J. and CASTELL, J. V., 1993, Inhibition of monooxygenase activities in human hepatocytes by interferons. Toxicology in Vitro, 7, 481–485.
   Google Scholar
• DOOSTDAR, H., DUTHIE, S. J., BURKE, M. D., MELVIN, W. T. and GRANT, M. H., 1988, The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line. FEBS Letters, 241, 15–18.
   PubMed Web of Science ®Google Scholar
• FUKUDA, Y., IsHroA, N., NOGUSHI, T., KAPPAS, A. and SASSA, S., 1992, Interleukin- 6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells. Biochernical and Biophysical Research Communications; 184, 960–965.
   PubMed Web of Science ®Google Scholar
• FUKUDA, Y. and SASSA, S., 1994, Suppression of cytochrome P4501A1 by interleukin- 6 in human HepG2 hepatoma cells. Biochemical Pharmacology, 47, 1187–1195.
   PubMed Web of Science ®Google Scholar
• GONZALEZ, J. G., 1992, Human cytochromes P450: problems and prospects. Trends in Pharmacological Sciences, 13, 346–352.
   PubMed Web of Science ®Google Scholar
• HAYASHI, S., WATANABE, J., NAKACHI, K., EGUCHI, H., GOTOH, O. and KAWAJIRI, K., 1994, Interindividual difference in expression of human Ah receptor and related P450 genes. CarcinogenesiN 15, 801–806.
   PubMedGoogle Scholar
• JAISWAL, A. K., GONZALEZ, F. J. and NEBERT, D. W., 1985, Human dioxin-inducible CytochrornePI-450 : complementary DNA and amino acid sequence. Science, 228, 80–83.
   PubMed Web of Science ®Google Scholar
• KIKUCHI, H., HOSSAIN, A., SAGAW, I., IKAWA, S. and WATANABE, M., 1995, Different inducibility of cytochrome P-4501A1 mRNA of human and mouse by omeprazole in culture cells. Archives of Biochemistry and Biophysics, 316, 649–652.
   PubMed Web of Science ®Google Scholar
• KIM, N. D., Yoo, J. K., WON, S. M., PARK, S. S. and GELBOIN, H. V., 1993, Phenytoin induction of cytochrome P4502B in mice: effects on hexobarbital hydroxylase activity. Xenobiotica, 23, 217–225.
   PubMedGoogle Scholar
• KNOWLES, B. B., HOWE, C. C. and ADEN, D. P., 1980, Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science, 209, 497–499.
   PubMed Web of Science ®Google Scholar
• KOCAREK, T. A., S CHUETZ, E. G., S TROM, S. C., FISHER, R. A. and GUZELIAN, P. S., 1995, Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition, 23, 415–421.
   PubMed Web of Science ®Google Scholar
• KOKUFU, T., IHARA, N., SUGIOKA, N., KOYAMA, H., OHTA, T., MORI, S. and NAKAJIMA, K., 1995, Effects of lansoprazole on pharmacokinetics and metabolism of theophylline. European Journal of Clinical Pharmacology, 48, 391–395.
   PubMed Web of Science ®Google Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LESCA, P., PERYT, B., LARRIEU, G., ALVINERIE, M., GAMER, P., DAUJAT, M., MAUREL, P. and HOOGENBOOM, L., 1995, Evidence for the ligand-independent activation of the AH receptor. Biochernical and Biophysical Research Communication. 209, 474–482.
   PubMed Web of Science ®Google Scholar
• Lipp, H. P., S CHRENK, D., WIESMULLER, T., HAGENMAIER, H. and BOCK, K. W., 1992, Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells. Archives of Toxicology, 66, 220–223.
   PubMedGoogle Scholar
• LUCAS, D., BERTHOU, F., DREANO, Y., LozAc'H, P., VOLANT, A. and MENEZ, J.-F., 1993, Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcoholism: Clinical and Experimental Research, 17, 900–905.
   Google Scholar
• MEREDTTH, M. J., 1988, Rat hepatocytes prepared without collagenase: prolonged retention of differentiated characteristics in culture. Cell Biology and Toxicology, 4, 405–425.
   PubMedGoogle Scholar
• MESNIL, M., FRASLIN, J. M., Piccou, C., YAMASAKI, H. and GUGUEN -GUILLOUZO, C., 1987, Cell contact but not junctional communication (dye coupling) with biliary epithelial cells is required for hepatocytes to maintain differentiated functions. Experimental Cell Research, 173, 524–532.
   Google Scholar
• NAKAMA, A., KURODA, K. and YAMAD A., 1995, Induction of cytochrome P450-dependent mono-oxygenase in serum- free cultured HepG2 cells. Biochemical Pharmacology, 50, 1407–1412.
   PubMed Web of Science ®Google Scholar
• NEDELCHEVA, V. and GUT, I., 1994, P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotica, 24, 1151–1175.
   PubMed Web of Science ®Google Scholar
• NEMOTO, N. and SAKURAI, J., 1994, Elevated expression of the CYP 1a2 gene in the presence of nicotinamide by adult mouse hepatocytes in primary culture. Archives of Biochemistry and Biophysics, 308, 292–298.
   PubMedGoogle Scholar
• NEMOTO, N., SAKURAI, J. and FUNAE, Y., 1995, Maintainance of phenobarbital-inducible Cyp2b gene expression in C57BL /6 mouse hepatocytes in primary culture as spheroids. Archives of Biochemistry and Biophysics, 316, 362–369.
   PubMedGoogle Scholar
• NOUSBAUM, J. B., BERTHOU, F., CARLHANT, D., RICHE, C., RonAszvanwicz, M. and GOUEROU, H., 1994, Four-week treatment with omeprazole increases the metabolism of caffeine. American Journal of Gastroenterology, 89, 371–375.
   PubMed Web of Science ®Google Scholar
• OLSZEWSKA, E., and JONES, K., 1988, Vacuum blotting enhances nucleic acid transfer. Trends in Genetics, 4, 92–94.
   PubMedGoogle Scholar
• PADGHAM, C. R., BOYLE, C. C., WANG, X. J., RALEIGH, S. M., WRIGHT, M. C. and PA, A. J., 1993, Alteration of transcription factor mRNAs during the isolation and culture of rat hepatocytes suggests the activation of a proliferative mode underlies their de-differentiation. Biochemical and Biophysical Research Communication. 197, 599–605.
   PubMed Web of Science ®Google Scholar
• PADGHAM, C. R. W. and PAINE, A. J., 1993, Altered expression of cytochrome P-450 mRNAs, and potentially of other transcripts encoding key hepatic functions, are triggered during the isolation of rat hepatocytes. Biochemical Journal, 289, 621–624.
   Google Scholar
• PADGHAM, C. R. W., PAINE, A. J., PHILLIPS, I. R. and S HEPHARD, E. A., 1992, Maintenance of total cytochrome p-450 content in rat hepatocyte culture and the abundance ofCYP1A2 and CYP2B1 mRNAs. Biochemical Journal, 285, 929–932.
   Google Scholar
• PONIE, P., NG, S. Y., ENGEL, J., GUNNING, P. and KEDES, L., 1984, Evolutionary conservation in the untran slated regions o f actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Research, 12, 1687–1696.
   PubMedGoogle Scholar
• PROUGH, R. A., BURKE, M. D. and MAYER, R. T., 1978, Direct fluorometric methods for measuring mixed- function oxidase activity. Methods in Enzymology, 52, 372–377.
   PubMedGoogle Scholar
• ROE, A. L., SNAWDER, J. E., BENSON, R. W., ROBERTS, D. W. and CASCIANO, D. A., 1993, HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. Biochernical and Biophysical Research Communication. 190, 15–19.
   PubMed Web of Science ®Google Scholar
• ROGIERS, V. and VERCRUYSSE, A., 1993, Rat hepatocyte cultures and co-cultures in biotransformation studies of xenobiotics. Toxicology, 82, 193–208.
   PubMed Web of Science ®Google Scholar
• ROST, K. L., BROSICKE, H., BROCKMOLLER, J., SCHEFFLER, M., HELGE, H. and ROOTS, I., 1992, Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C4N-3-methyl]- caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clinical Pharmacology and Therapeutics, 52, 170–180.
   PubMed Web of Science ®Google Scholar
• SACHS, G., Slim-, J. M., BRIVING, C., WALLMARK, B. and HERSEY, S., 1995, The pharmacology of the gastric acid pump: theATPase. Annual Review of Pharmacology and Toxicology, 35,277–305.
   Google Scholar
• SAMBROOK, J., FRITSCH, E. F. and MANIATIS, T., 1989, Molecular Cloning (Cold Spring Harbor: Cold Spring Harbor Laboratory Press), 7.40–7.42.
   Google Scholar
• SASSA, S., SuGrrA, O., GALBRAITH, R. A. and KAPPAS, A., 1987, Drug metabolism by the human hepatoma cell, HepG2. Biochemical and Biophysical Research Communication. 143, 52–57.
   PubMed Web of Science ®Google Scholar
• SCHMALIX, W. A., MASER, H., KIEFER, F., REEN, R., WIEBEL, F. J., GONZALEZ, F., S EIDEL, A., GLATT, H., GAHM, H. and DOEHMER, J., 1993, Stable expression of human cytochrome P450 1A1 cDNA in V79 Chinese hamster cells and metabolic activation of benzo[a]pyrene. European Journal of Pharmacology/Environmental Toxicology and Pharmacology Section, 248, 251–261.
   Google Scholar
• SCHWEIKL, H., TAYLOR, J. A., KITAREEWAN, S., LINKO, P., NAGORNEY, D. and GOLDSTEIN, J. A., 1993, Expression of CYP1A1 and CYP1A2 genes in human liver. PharrnacogenetiaN 3, 239–249.
   PubMedGoogle Scholar
• SIDHU, J. S., FARIN, F. M., KAVANAGH, T. J. and OMIECINSKI, C. J., 1994, Effect of tissue-culture substratum and extracellular matrix overlay on liver- selective and xenobiotic inducible gene expression in primary rat hepatocytes. In Vitro Toxicology, 7, 225–242.
   PubMedGoogle Scholar
• SIMON, W. A., BUDINGEN, C., FAHR, S., KINDER, B. and KOSKE, M., 1991, The H7IC-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole. Biochemical Pharmacology, 42, 347–355.
   PubMed Web of Science ®Google Scholar
• STEINIJANS, V. W., HUBER, R., HARTMANN, M., ZECH, K., BLIESATH, H., WURST, W. and RADTKE, H. W., 1994, Lack of pantoprazole drug interactions in man. International Journal of Clinical Pharmacology and Therapeutics, 32, 385–399.
   PubMedGoogle Scholar
• THOMAS, H., SAGELSDORF, P., MOLITOR, E., SKRIPSKY, T. and WACITIER, F., 1994, Bromopropylate: induction of hepatic cytochromes P450 and absence of covalent binding to DNA in mouse liver. Toxicology and Applied Pharmacology, 129, 155–162.
   PubMedGoogle Scholar
• UTESCH, D., Mouroa, E., PLATT, K.-L. and OESCH, F., 1991, Differential stabilization of cytochrome P-450 isoenzymes in primary cultures of adult rat liver parenchymal cells. In Vitro Cellular and Developmental Biology, 27A, 858–863.
   Google Scholar
• VENKATESAN, K., 1992, Pharmacokinetic drug interactions with rifampicin. Clinical Pharrnacokinetics 22, 47–65.
   PubMed Web of Science ®Google Scholar